Skip to main content
BCAB logo

BioAtla, Inc.

BCABNASDAQHealthcareBiotechnology

$1.30Today:- (-)1Y +56.68%

As of Oct 15, 2026 close

Market cap
$2.16M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.41$23.65
Volume (live)
-
Avg. volume (3M)
17.12K

BioAtla (BCAB) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), BioAtla used $48.20M of cash in operating activities. Free cash flow was −$48.20M.

BioAtla Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for BioAtla, Inc. (BCAB) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-59.61-69.78-123.46-106.48-95.40-35.85-29.86-28.98
Depreciation & Amortization0.370.931.221.201.331.010.860.79
Deferred Income Tax0.000.000.000.00-0.694.460.010.00
Stock Based Compensation5.438.9213.5414.5625.123.02-0.010.00
Change in Working Capital4.28-11.204.680.297.42-3.3625.10-9.70
Change in Accounts Payable2.80-13.465.283.417.99-1.663.130.45
Change in Other Working Capital1.472.26-0.60-3.120.00-1.2721.97-10.15
Other Operating Activities1.32-0.810.000.010.00-1.15-5.752.57
Net Cash from Operating Activities-48.20-71.94-104.02-90.42-62.21-36.33-9.65-35.32
Investing Activities
Capital Expenditures0.000.00-0.10-0.27-0.92-0.59-1.51-0.99
Acquisitions0.000.000.000.000.00-0.020.000.02
Other Investing Activities0.000.000.000.000.000.020.010.00
Net Cash from Investing Activities0.000.00-0.10-0.27-0.92-0.59-1.51-0.99
Financing Activities
Debt Repayment7.130.000.000.000.003.434.005.00
Common Stock Issued0.109.220.3461.6870.99200.230.000.00
Common Stock Repurchased0.000.00-0.260.000.000.000.000.00
Other Financing Activities-0.950.30-0.26-0.47-1.91-4.340.000.02
Net Cash from Financing Activities6.289.510.0861.2169.51271.834.005.02
Summary
Net Change in Cash-41.93-62.43-104.04-29.476.37234.90-7.16-31.29
Cash at Beginning of Period49.05111.47215.51244.98238.613.7010.8642.15
Cash at End of Period7.1249.05111.47215.51244.98238.613.7010.86
Free Cash Flow-48.20-71.94-104.11-90.69-63.14-36.92-11.15-36.31

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioAtla Cash Flow

What is BioAtla's free cash flow?

BioAtla had negative free cash flow of $48.20M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does BioAtla pay dividends or buy back shares?

BioAtla's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition